Po-Yuan Lin

Title: Po-Yuan Lin: Innovator in Prostate Cancer Detection

Introduction

Po-Yuan Lin is a notable inventor based in Cleveland, OH (US). He has made significant contributions to the field of medical diagnostics, particularly in the detection of prostate cancer. His innovative work has the potential to improve early detection and treatment outcomes for patients.

Latest Patents

Po-Yuan Lin holds a patent for a system and method for detecting alpha-methylacyl-CoA racemase (AMACR) and prostate cancer. This detection system is designed to determine alpha-methylacyl-CoA (AMACR) levels in bodily samples. The system includes at least one reaction solution that generates hydrogen peroxide (HO) upon interaction with AMACR in the sample. The reaction solution comprises a (2R)-2-methylacyl-CoA epimer, which can be chirally inverted by AMACR to a (2S)-2-methylacyl-CoA epimer, along with an enzyme that facilitates beta oxidation to produce hydrogen peroxide.

Career Highlights

Po-Yuan Lin is affiliated with Case Western Reserve University, where he continues to advance research in medical diagnostics. His work is characterized by a commitment to innovation and improving healthcare outcomes through technology.

Collaborations

He collaborates with esteemed colleagues, including Chung Chiun Liu and Laurie Dudik, to further enhance the impact of his research and inventions.

Conclusion

Po-Yuan Lin's contributions to the field of prostate cancer detection exemplify the importance of innovation in medical technology. His patent reflects a significant advancement that could lead to better diagnostic methods and improved patient care.